Zobrazeno 1 - 10
of 14
pro vyhledávání: '"national cancer database and seer analyses"'
Publikováno v:
Cureus
Purpose/objectives Induction chemotherapy followed by chemoradiation and surgical resection in rectal cancer, known as total neoadjuvant therapy (TNT), is associated with improved pathologic complete response (pCR) rates. The National Cancer Database
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f561b2ac658e8069f6a4a94ccb7a7e9a
https://doi.org/10.7759/cureus.17233
https://doi.org/10.7759/cureus.17233
Publikováno v:
Cureus
Introduction Pleural mesothelioma constitutes about 80% of all mesotheliomas. The peak incidence of malignant mesothelioma estimated using the cancer registries was in early 1990 to 2000 in the United States. The disease is primarily associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933b3eb0a654dc5926853f0a47b80fbe
https://pubmed.ncbi.nlm.nih.gov/34040906
https://pubmed.ncbi.nlm.nih.gov/34040906
Autor:
Chris Anama-Green, Megan Quinn
Publikováno v:
Cureus
Background Although pancreatic cancer incidence is low at 13.1 per 100,000 people, this cancer is difficult to treat and carries a poor 5-year survival rate. Additionally, pancreatic cancer survival rates vary disproportionately based on age and race
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509a5d879da430d4f9894afe3609ad77
https://pubmed.ncbi.nlm.nih.gov/33665053
https://pubmed.ncbi.nlm.nih.gov/33665053
Autor:
Daniel Rapado, Pura Rodriguez de la Vega, Sean Chowdhari, Juan Manuel Lozano, Marcia Varella, Chan Gu, Grettel Castro
Publikováno v:
Cureus
Introduction and objective Hodgkin’s lymphoma (HL) is a form of cancer originating from white blood cells that presents upon diagnosis with well-characterized symptoms (palpable lymph nodes, fever, night sweats, weight loss). HL is currently one of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba0b1a719571a11e2c70ba30c9aa982
https://doi.org/10.7759/cureus.11600
https://doi.org/10.7759/cureus.11600
Publikováno v:
ETSU Faculty Works.
Introduction Pleural mesothelioma constitutes about 80% of all mesotheliomas. The peak incidence of malignant mesothelioma estimated using the cancer registries was in early 1990 to 2000 in the United States. The disease is primarily associated with
Externí odkaz:
https://dc.etsu.edu/etsu-works-2/131
Autor:
Anama-Green, Chris, Quinn, Megan A.
Publikováno v:
ETSU Faculty Works.
Background Although pancreatic cancer incidence is low at 13.1 per 100,000 people, this cancer is difficult to treat and carries a poor 5-year survival rate. Additionally, pancreatic cancer survival rates vary disproportionately based on age and race
Externí odkaz:
https://dc.etsu.edu/etsu-works-2/94
Autor:
Alhadeethi A; General Medicine, Al-Salam Teaching Hospital, Mosul, IRQ.; General Medicine, Medical Research Group of Egypt, Negida Academy LCC, Arlington, USA., Atia A; Oncology, Faculty of Medicine Kasr Al-Ainy, Cairo University, Cairo, EGY., Alkhawaldeh IM; Cardiology, Faculty of Medicine, Mu'tah University, Karak, JOR., Ibrahim AA; Cardiology, Faculty of Medicine, Menoufia University, Shibin El Kom, EGY., Afifi E; Urology, Faculty of Medicine, Benha University, Benha, EGY., Elwekel A; Cardiology, Faculty of Medicine, Al-Azhar University, Cairo, EGY., Nouh A; Oncology, Faculty of Medicine, Sohag University, Sohag, EGY., Morsi MH; Urology, Misr University for Science and Technology, 6th of October City, EGY.
Publikováno v:
Cureus [Cureus] 2023 Dec 29; Vol. 15 (12), pp. e51279. Date of Electronic Publication: 2023 Dec 29 (Print Publication: 2023).
Autor:
Waters MR; Radiation Oncology, Washington University School of Medicine, St. Louis, USA., Andruska N; Radiation Oncology, Washington University School of Medicine, St. Louis, USA., Fischer-Valuck BW; Radiation Oncology, Emory University School of Medicine, Atlanta, USA., Agabalogun T; Radiation Oncology, Washington University School of Medicine, St. Loui, USA., Brenneman RJ; Radiation Oncology, Washington University School of Medicine, St. Louis, USA., Gay H; Radiation Oncology, Washington University School of Medicine, St. Louis, USA., Michalski JM; Radiation Oncology, Washington University School of Medicine, St. Louis, USA., Baumann B; Radiation Oncology, Washington University School of Medicine, St. Louis, USA.
Publikováno v:
Cureus [Cureus] 2023 Jan 29; Vol. 15 (1), pp. e34351. Date of Electronic Publication: 2023 Jan 29 (Print Publication: 2023).
Autor:
Silver B; Radiation Oncology, State University of New York Downstate Medical Center, Brooklyn, USA., Mattessich S; Radiation Oncology, State University of New York Downstate Medical Center, Brooklyn, USA., Yacoub I; Radiation Oncology, State University of New York Downstate Medical Center, Brooklyn, USA., Rhee B; Radiation Oncology, State University of New York Downstate Medical Center, Brooklyn, USA., Schreiber D; Radiation Oncology, Summit Medical Group, Berkeley Heights, USA.
Publikováno v:
Cureus [Cureus] 2022 Aug 21; Vol. 14 (8), pp. e28223. Date of Electronic Publication: 2022 Aug 21 (Print Publication: 2022).
Autor:
Al-Juhaishi T; Hematology and Medical Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, USA., Deng X; Biostatistics, Virginia Commonwealth University, Richmond, USA., Bandyopadhyay D; Biostatistics, Virginia Commonwealth University, Richmond, USA., Paul A; Hematology and Medical Oncology, Virginia Commonwealth University School of Medicine, Richmond, USA.
Publikováno v:
Cureus [Cureus] 2022 May 27; Vol. 14 (5), pp. e25395. Date of Electronic Publication: 2022 May 27 (Print Publication: 2022).